Moray Medical news
Moray Medical is honored to be chosen from a pool of 1000+ applicants by MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, as one of 50 leading medtech startups transforming the healthcare industry.
Moray will participMedical device development company Ximedica, Providence, RI, interviewed Moray Medical founders Mark Barrish and Phillip Laby for a feature on their company blog. Ximedica is a sponsor of Medtech Innovator, and their team mentors and advises many of the accelerator’s startups. Moray was one of the 5 top finalists out of 1,000 candidates i
The Cleveland Clinic showcased a webinar on “The Emerging Robotic Ecosystem,” discussing medical robotics commercialization hurdles in the COVID-19 era. CEOs and leaders from cutting-edge robotics startups, including Mark Barrish, CEO, Moray Medical, also shared future predictions for the field, and areas ripe for innovation via robotic technology. The group included Lisa Carmel, Vice President Strategy, Ximedica, Eric Davidson, President, Flexible Robotics, Auris, L
Mark Barrish, CEO of Moray Medical, gave an interview to Medgadget, a well-known source for international medical technology news, health care trends, and medical research. Reporter Conn Hastings elicited clear, precise answers to questions ranging from the basics of heart valve failure to t
Co-founder Mark Barrish appeared on MedTech Chat with Tom Donnelly, to discuss how Moray Medical is bringing the benefits of robotics to structural heart repair. (Linked page includes both podcast audio and written transcript.)
MedTech Innovator, the largest accelerator of medical devices in the world, today announced the finalists for MedTech Innovator’s eighth annual competition: Cellvie, Circadia Health, Lief Therapeutics, Moray Medical, and Rhaeos. Virtual attendees of The MedTech Confere
CM Medical included Moray Medical’s technology in their “6 of the Best in Structural Heart” roundup. “They’ve made a robot which has less than 200 mechanical parts end to end, which is extremely unusual for the robotic medical device market.” Author James Christopher points out. “With leaders boasting compani
An esteemed panel of subject matter experts, clinicians, and investors selected Moray Medical (then called Project Moray) as a Rosenman Innovator for its innovative technology and patient impact, digitizing the user interface of cardiac catheter systems to enable precise delivery of therapies within the beating hearts of millions of patients.